Drug Development
Model-Informed Drug Development (MIDD) - EMA's Advancement
MS is used in all phases of drug development in the EU US and UK starting from preclinical pharmacokinetic PK and pharmacokineticpharmacodynamics PKPD studies through clinical trials to postmarketing commitments
Human Vaccine Candidates Discovery and Development on Non-Animal Systems
An adoption with meaningful repercussions
A vaccine is traditionally a biological substance containing a harmless form of the causative organism that causes a particular disease It is usually given to healthy population by injection to prevent the contraction of the disease
DIGITAL SOLUTIONS IN DRUG DEVELOPMENT
Regulations to enable safe, effective, and high-quality solutions
From mobile medical apps and fitness trackers to software that supports the clinical decisions that doctors make every day digital technology has been driving a revolution in healthcare As we learn to live in the new normal forced by the COVID pandemic adoption of digital solutions has witnessed further acceleration
THE USE OF CRYSTAL ENGINEERING TO EFFECTIVELY TARGET LUNG INFECTIONS
Lung infections especially lower respiratory tract infections are one of the leading causes of transmissible deaths worldwide according the world health organisation
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
The earliest example of in vivo expression of exogenous mRNA was by direct intramuscular injection in mice without the aid of a delivery vehicle This appears to defy what is known about nucleic acids being that they are large polar and metabolically unstable drugs that do not cross cell membranes However since cytoplasmic delivery is essential for...
